The effect of galectin 1 on 3T3 cell proliferation on chitosan membranes

Biomaterials

Volumn 25, Issue 17, 2004, Pages 3603-3611

  Chang, Yu Ying ^a   Chen, Shiang Jiuun ^b   Liang, Huang Chien ^c   Sung, Hsing Wen ^c   Lin, Chien Chung ^a,d   Huang, Rong Nan ^a  

^a NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Chitin; Chitosan membrane; Galectin; Phosphotyrosine

Indexed keywords

ADHESION; ANTIBODIES; CELL MEMBRANES; CYTOLOGY; ENZYMES; IMMUNOLOGY; TOXICITY;

PHOSPHORYLATION;

BIOMATERIALS;

CHITOSAN; FLUORIDE SODIUM; GALECTIN 1; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; THIOGLYCOSIDE;

ANIMAL CELL; ARTICLE; ARTIFICIAL MEMBRANE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

3T3 CELLS; ANIMALS; BIOLOGICAL DRESSINGS; CELL DIVISION; CELL SIZE; CHITIN; CHITOSAN; COATED MATERIALS, BIOCOMPATIBLE; DOSE-RESPONSE RELATIONSHIP, DRUG; GALECTIN 1; MATERIALS TESTING; MEMBRANES, ARTIFICIAL; MICE;

DECAPODA (CRUSTACEA); LOBSTER;

EID: 1542358697     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2003.10.039     Document Type: Article

References (47)

1. Barondes S.H. Galectins. a family of animal beta-galectoside-binding lectins Cell. 76:1994;597-598.
2. Hirabayashi J., Kasai K. The family of metazoan metal-independent beta-galactoside-binding lectins. structure, function and molecular evolution Glycobiology. 3:1993;297-304.
3. Barondes S.H., Cooper D.N., Gitt M.A., Leffler H. Galectins. Structure and function of a large family of animal lectins. J Biol Chem. 269:1994;20807-20810.
4. Perillo N.L., Pace K.E., Seilhamer J.J., Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature. 378:1995;736-739.
5. Vyakarnam A., Dagher S.F., Wang J.L., Patterson R.J. Evidence for a role for galectin-1 in pre-mRNA splicing. Mol Cell Biol. 17:1997;4730-4737.
6. Giancotti F.G. Integrin signalling. specificity and control of cell survival and cell progression Curr Opin Cell Biol. 9:1997;691-700.
7. Assoian R.K., Marcantonio E.E. The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis. J Clin Invest. 110(11S):1997;S15-S18.
8. Moiseeva E.P., Javed Q., Spring E.L., de Bono D.P. Galectin 1 is involved in vascular smooth muscle cell proliferation. Cardiovas Res. 45:2000;493-502.
9. Yamaoka K., Ingendoh A., Tsubuki S., Nagai Y., Sanai Y. Structural and functional characterization of a novel tumor-derived rat galectin-1 having transforming growth factor (TGF) activity. the relationship between intramolecular disulfide bridges and TGF activity J Biochem. 119:1996;878-886.
10. Adams L., Scott G.K., Weinberg C.S. Biphasic modulation of cell growth by recombinant human galectin-1. Biochim Biophys Acta. 1312:1996;137-144.
11. Yamaoka K., Ohno S., Kawasaki H., Suzuki K. Overexpression of a beta-galactoside-binding protein causes transformation of BALB3T3 fibroblast cells. Biochem Biophys Res Commun. 179:1991;272-279.
12. Well V., Mallucci L. Identification of an autocrine negative growth factor. mouse beta-galactoside-binding protein is a cytostatic factor and cell growth regulator Cell. 64:1991;91-97.
13. Su C.H., Sun C.S., Juan S.W., Hu C.H., Ke W.T., Sheu M.T. Fungal mycelia as the source of chitin and polysaccharides and their applications as skin substitutes. Biomaterials. 18:1997;1169-1174.
14. Biagini G., Bertani A., Muzzarelli R.et al. Wound management with N-carboxybutyl chitosan. Biomaterials. 12:1991;281-286.
15. Berthod F., Hayek D., Damour O., Collombel C. Collagen synthesis by fibroblasts cultured within a collagen sponge. Biomaterials. 14:1993;749-754.
16. Abhay SP. Hemostatic wound dressing. United States Patent No. 1998; 5836970.
17. Dagalakis N., Flink J., Stasikelis P., Burke J.F., Yannas I.V. Design of an artificial skin. Part III. Control of pore structure. J Biomed Mater Res. 14:1980;511-528.
18. Matsuda K., Suzuki S., Isshiki N.et al. Evaluation of a bilayer artificial skin capable of sustained release of an antibiotic. Biomaterials. 13:1992;119-122.
19. Yannas I.V., Burke J.F., Gordon P.L., Huang C., Rubenstein R.H. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res. 14:1980;107-132.
20. Chung L.Y., Schmidt R.J., Hamlyn P.F., Sagar B.F., Andrews A.M., Turner T.D. Biocompatibility of potential wound management products. fungal mycelia as a source of chitin/chitosan and their effect on the proliferation of human f1000 fibroblasts in culture J Biomed Mater Res. 28:1994;463-469.
21. William GM, Herbert JQ. Methods of achieving hemostasis inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound. United States Patent No. 1985; 4532134.
22. Tomihata K., Ikada Y. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials. 18:1997;567-575.
23. Muzzarelli R., Tarsi R., Filippini O., Giovanetti E., Biagini G., Varaldo P.E. Antimicrobial properties of N-carboxybutyl chitosan. Antimicrob Agents Chemother. 34:1990;2019-2023.
24. Mi F.L., Shyu S.S., Wu Y.B., Lee S.T., Shyong J.Y., Huang R.N. Fabrication and characterization of a sponge-like asymmetric chitosan membrane as a wound dressing. Biomaterials. 22:2001;165-173.
25. Mi F.L., Tan Y.C., Liang H.C., Huang R.N., Sung H.W. In vitro evaluation of a chitosan membrane crosslinked by genipin. J Biomater Sci Polym Ed. 12:2001;835-850.
26. Mori T., Irie Y., Nishimura S.I.et al. Endothelial cell responses to chitin and its derivatives. J Biomed Mater Res. 43:1998;469-472.
27. Mori T., Okumura M., Matsuura M.et al. Effects of chitin and its derivatives on the proliferation and cytokine production of fibroblasts in vitro. Biomaterials. 18:1997;947-951.
28. Chang K.N., Lee T.C., Tam M.F.et al. Identification of galectin I and thioredoxin peroxidase II as two arsenic binding proteins in Chinese hamster ovary cells. Biochem J. 371:2003;495-503.
29. Eshhar Z. Hybridoma technology in the biosciences and medicine. Springer T. Hybridoma in biotechnology and medicine. 1985;1-41 Plenum Publishing Corp. New York.
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
31. Bradford M.A. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the priciple of protein dye binding. Anal Biochem. 72:1976;248-254.
32. Chiariotti L., Benvenuto G., Zarrilli R.et al. Activation of the galectin-1 (L-14-I) gene from nonexpressing differentiated cells by fusion with undifferentiated and tumorigenic cells. Cell Growth Differ. 5:1994;769-775.
33. Kopitz J., Von Reitzenstein C., Burchert M., Cantz M., Gabius H.J. Galectin-1 is a major receptor for ganglioside GM-1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J Biol Chem. 273:1998;11205-11211.
34. Thom V.H., Altankov G., Groth T., Jankova K., Jonsson G., Ulbricht M. Optimising cell-surface interactions by photographing of poly(ethylene glycol). Langmuir. 16:2000;2756-2765.
35. Tharanathan R.N., Kittur F.S. Chitin-the undisputed biomolecule of great potential. Crit Rev Food Sci Nutr. 43:2003;61-87.
36. Van den Brule F.A., Buicu C., Baldet M.et al. Galectin-1 modulates human melanoma cell adhesion to laminin. Biochem Biophys Res Commun. 209:1995;760-767.
37. Hafer Macko C., Pang M., Seilhamer J.J., Baum L.G. Galectin-1 is expressed by thymic epithelial cells in myasthenia gravis. Glycoconj J. 13:1996;591-597.
38. Cooper D.N., Barondes S.H. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J Cell Biol. 110:1990;1681-1691.
39. Retta S.F., Ternullo M., Tarone G. Adhesion to matrix proteins. Methods Mol Biol. 96:1999;125-130.
40. Aplin A.E., Howe A., Alahari S.K., Juliano R.L. Signal transduction and signal modulation by cell adhesion receptors. the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins Pharmacol Rev. 50:1998;197-263.
41. Walzel H., Schulz U., Neels P., Brock J. Galectin-1, a natural ligand for the receptor-type protein tyrosine phosphatase CD45. Immunol Lett. 67:1999;193-202.
42. Fouillit M., Joubert Caron R., Poirier F.et al. Regulation of CD45-induced signaling by galectin-1 in Burkitt lymphoma B cells. Glycobiology. 10:2000;413-419.
43. Fouillit M., Poirier F., Monostori E.et al. Analysis of galectin 1-mediated cell signaling by combined precipitation and electrophoresis techniques. Electrophoresis. 21:2000;275-280.
44. Tonks N.K., Charbonneau H., Diltz C.D., Fischer E.H., Walsh K.A. Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase. Biochemistry. 27:1988;8695-8701.
45. Maeda N., Kawada N., Seki S.et al. Stimulation of proliferation of rat hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways. J Biol Chem. 278:2003;18938-18944.
46. Sommer F., Klotz T., Steinritz D.et al. MAP kinase 1/2 (Erk 1/2) and serine/threonine specific protein kinase Akt/PKB expression and activity in the human corpus cavernosum. Int J Impotence Res. 14:2002;217-225.
47. Crews C.M., Alessandrini A.A., Erikson R.L. Mouse Erk-1 gene product is a serine/threonine protein kinase that has the potential to phosphorylate tyrosine. Proc Nat Acad Sci USA. 88:1991;8845-8849.